Phase 2 Study of Selinexor in Patients with Myelodysplastic Syndromes Refractory to Hypomethylating Agents: Interim ReportV.M. Klimek, M. Coleman,K. Alvarez,F. Sen,J. Pichardo,T. Kashyap,B. KlebanovLeukemia Research(2017)引用 0|浏览5暂无评分关键词Myeloid NeoplasmsAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要